Boys are prescribed ADHD medication more frequently than girls due to higher diagnosis rates, differences in symptom presentation, and systemic biases in healthcare. Approximately 15% of boys are diagnosed with ADHD compared to 8% of girls, with boys more likely to exhibit hyperactive/impulsive behaviors that prompt teacher and parent referrals. Medication treatment rates reflect this gap: 15.7% of boys with ADHD receive prescriptions versus 7% of girls.

– Boys often display disruptive behaviors (e.g., fidgeting, interrupting), while girls frequently show less conspicuous inattentive symptoms.
– Clinicians may underrecognize ADHD in girls, delaying or preventing treatment.
– White children are 14.8% more likely to receive medication than Black children (9.4%), and low-income families often rely on medications due to limited access to behavioral therapies.

– Medication errors involving ADHD drugs surged 299% from 2000–2021, disproportionately affecting boys (76% of cases).
– Nearly 30% of children with ADHD received no medication or behavioral therapy in 2022, highlighting gaps in care accessibility.

These patterns underscore the need for gender-inclusive diagnostic criteria and expanded access to non-pharmacological interventions to ensure equitable treatment.

—
supplement claims to support energy and immunity but lacks peer-reviewed evidence for ADHD-related benefits. Its 150-ingredient formula includes vitamins, minerals, and herbs, though proprietary blends obscure exact dosages.